BridgeMD
Compares treatment options for Seizure
Official title Levetiracetam Versus Phenobarbital in Benzodiazepines Unresponsive Paediatric Prolonged Seizures
ClinicalTrials.gov ID: NCT07098728
What this study is testing
What is Levetiracetam IV?
Levetiracetam IV is an investigational medicine, given as an once-daily infusion into a vein, being studied as a potential treatment for seizure.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Convulsive prolonged seizures in children are the most common life-threatening neurological emergencies. The aim of active management of seizure control is to prevent irreversible neuronal damage as early as possible.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 12
You may be able to join if
- Children aged between 1 month to 12 years with prolonged seizures who do not respond to any two bolus doses of benzodiazepines
You likely can't join if
- Any of the following criteria will be excluded.
- Children who receive anticonvulsant treatment other than benzodiazepines for the acute management of prolonged seizures
- Acute symptomatic seizures due to hypertensive encephalopathy or hypoglycaemia
- Presence of arrythmia or respiratory depression
- Known case of chronic kidney disease or chronic liver disease
The study team makes the final eligibility decision.
Where it's taking place
- Yangon, Yangon, Burma
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 month to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Yangon, Yangon, Burma. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.